Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies

By Birbara C.   Ruoff G.   Sheldon E.   Valenzuela C.   Rodgers A.   Petruschke R. A.   Chang D. J.   Tershakovec A. M.  

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-01 ,pp. : 199-210

Informa Healthcare

Access to resources Recommend Favorite

The VIOXX in prostate cancer prevention study: cardiovascular events observed in the rofecoxib 25 mg and placebo treatment groups

By van Adelsberg Janet   Gann Peter   Ko Amy T.   Damber Jan-Erik   Logothetis Christopher   Marberger Michael   Schmitz-Drager Bernd J.   Tubaro Andrea   Roehrborn Celiaus  

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2063-2070

Informa Healthcare

Access to resources Recommend Favorite

Perioperative Schmerztherapie mit Rofecoxib: Wie wirksam ist die präoperative Gabe einer 25-mg-Dosis bei muskuloskelettalen Operationen?

By Steffen P.   Krell M.   Seeling W.  

Der Schmerz, Vol. 18, Iss. 4, 2004-08 ,pp. : 278-285

Springer Publishing Company

Access to resources Recommend Favorite

The efficacy of rofecoxib 50 mg and hydrocodone/acetaminophen 7.5/750 mg in patients with post-arthroscopic pain

By Chelly Jacques E.   Nissen Carl W.   Rodgers Anthony J.   Smugar Steven S.   Tershakovec Andrew M.  

Current Medical Research and Opinion, Vol. 23, Iss. 1, 2007-01 ,pp. : 195-206

Informa Healthcare

Access to resources Recommend Favorite

Meta-Analysis of the Efficacy of Ebastine 20 mg Compared to Loratadine 10 mg and Placebo in the Symptomatic Treatment of Seasonal Allergic Rhinitis

By  

International Archives of Allergy and Immunology, Vol. 138, Iss. 4, 2005-11 ,pp. : 312-318

Karger

Access to resources Recommend Favorite